Biovest Expanding in Coon Rapids, Minnesota, to Develop Cancer Vaccine
02/25/2011
The Coon Rapids Housing and Redevelopment Authority will contribute an additional $100,000 and facility owner JMS Holdings will invest $1.15 million in facility improvements.
"The Minneapolis area is rich with resources vital to a biotechnology company's growth needs, and it is with great appreciation that we thank the state of Minnesota, the city of Coon Rapids, and JMS Holdings for investing in our future," said Biovest President Samuel Duffey.
Biovest will add 14 jobs to its existing work force of 24 employees. It is planning to produce the first cancer vaccine to treat non-Hodgkin's lymphoma. The company has been located in Coon Rapids for nearly 30 years.
Project Announcements
PEAK Precision Manufacturing Plans Bowling Green, Kentucky, Operations
07/26/2024
Italy-Based Sipcam Agro USA Upgrades Wayne County, Mississippi, Operations
07/26/2024
Cleveland-Cliffs Plans Weirton, West Virginia, Operations
07/26/2024
IDEXX Laboratories Plans Wilson, North Carolina, Production Operations
07/26/2024
Germany-Based Ritz Instrument Transformers Plans Waynesboro, Georgia, Operations
07/26/2024
AirJoule Plans Newark-Wilmington, Delaware, Operations
07/26/2024
Most Read
-
19th Annual Area Development Gold and Silver Shovel Awards
Q2 2024
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The CHIPS and Science Act will bring jobs back to the United States
Q2 2024
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
The Bring Your Own Energy (BYOE) Party Is Starting
Q2 2024
-
Midwest becomes hotspot for semiconductor manufacturing and supply industries
Q2 2024